[go: up one dir, main page]

CN110041475B - Amphiphilic block copolymer, shell-crosslinked micelle thereof, preparation method and application - Google Patents

Amphiphilic block copolymer, shell-crosslinked micelle thereof, preparation method and application Download PDF

Info

Publication number
CN110041475B
CN110041475B CN201910291982.7A CN201910291982A CN110041475B CN 110041475 B CN110041475 B CN 110041475B CN 201910291982 A CN201910291982 A CN 201910291982A CN 110041475 B CN110041475 B CN 110041475B
Authority
CN
China
Prior art keywords
block copolymer
amphiphilic block
formula
micelle
cross
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910291982.7A
Other languages
Chinese (zh)
Other versions
CN110041475A (en
Inventor
张国颖
吴学
刘固寰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Science and Technology of China USTC
Original Assignee
University of Science and Technology of China USTC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Science and Technology of China USTC filed Critical University of Science and Technology of China USTC
Priority to CN201910291982.7A priority Critical patent/CN110041475B/en
Publication of CN110041475A publication Critical patent/CN110041475A/en
Application granted granted Critical
Publication of CN110041475B publication Critical patent/CN110041475B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/38Polymerisation using regulators, e.g. chain terminating agents, e.g. telomerisation
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2/00Processes of polymerisation
    • C08F2/46Polymerisation initiated by wave energy or particle radiation
    • C08F2/48Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light
    • C08F2/50Polymerisation initiated by wave energy or particle radiation by ultraviolet or visible light with sensitising agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F293/00Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
    • C08F293/005Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F2438/00Living radical polymerisation
    • C08F2438/03Use of a di- or tri-thiocarbonylthio compound, e.g. di- or tri-thioester, di- or tri-thiocarbamate, or a xanthate as chain transfer agent, e.g . Reversible Addition Fragmentation chain Transfer [RAFT] or Macromolecular Design via Interchange of Xanthates [MADIX]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

本发明提供一种两亲性嵌段共聚物、由其组成的聚合物纳米壳交联胶束以及它们的制备方法和应用。所述两亲性嵌段共聚物由亲水链段和在中性以及碱性环境中呈现疏水特性的疏水链段通过可逆加成‑断裂链转移(RAFT)聚合获得,其中所述亲水链段是寡聚乙二醇甲基丙烯酸酯与带有用于壳交联的醛基功能团的甲基丙烯酸酯类化合物共聚得到,其分子量为5000~10000Da。本发明实现了聚合物纳米壳交联胶束载体负载的疏水药物的可控释放,同时两亲性嵌段共聚物中共价键结合的具有红光发射的光敏剂以及用于壳交联的醛基功能团配合在中性以及碱性环境中呈现疏水特性的疏水链段,能够在弱酸的微环境中以及红光照射的激发下准确地实现药物的可控释放。

Figure DDA0002024354220000011
The invention provides an amphiphilic block copolymer, a polymer nanoshell cross-linked micelle composed thereof, and a preparation method and application thereof. The amphiphilic block copolymer is obtained by reversible addition-fragmentation chain transfer (RAFT) polymerization of hydrophilic segments and hydrophobic segments exhibiting hydrophobic properties in neutral and alkaline environments, wherein the hydrophilic chains The segment is obtained by copolymerizing oligoethylene glycol methacrylate and a methacrylate compound with an aldehyde functional group for shell crosslinking, and its molecular weight is 5000-10000 Da. The invention realizes the controllable release of the hydrophobic drug loaded by the polymer nanoshell cross-linked micelle carrier, and at the same time, the amphiphilic block copolymer is covalently bonded to a photosensitizer with red light emission and an aldehyde for shell cross-linking. The functional group is matched with a hydrophobic segment that exhibits hydrophobic properties in neutral and alkaline environments, and can accurately achieve controlled release of drugs in a weak acid microenvironment and under the excitation of red light irradiation.
Figure DDA0002024354220000011

Description

Amphiphilic block copolymer, shell-crosslinked micelle thereof, preparation method and application
Technical Field
The invention belongs to the field of high polymer materials and preparation and application thereof. In particular to an amphiphilic block copolymer with stimulus responsiveness, a polymer nano micelle composed of the amphiphilic block copolymer, and a preparation method and application thereof.
Background
The high bionics of various structural functions realized by simulating a cell structure by using a supermolecular assembly is always concerned by people, and particularly, the nano-assembly of the amphiphilic block copolymer is used for realizing the drug delivery of the focus part of a human body. However, although the block copolymer formed assemblies exhibit better thermodynamic stability compared to small molecule surfactants due to their lower Critical Micellization Concentration (CMC), there are some uncontrollable factors that may lead to the destruction and dissociation of the block copolymer assemblies, such as temperature, concentration, and solvent conditions (Elsabayy M, Heo G S, LimSM, Chemical revlews, 2015, 115 (19): 10967-11011). For drug delivery systems using block copolymer assemblies as carriers, stability of the assemblies is particularly important in avoiding premature release of the drug, prolonging blood circulation time, and increasing the therapeutic effect of the drug (Talelli M, Barz M, Rijcken C JF, Nano today, 2015, 10 (1): 93-117). The focus of the research in recent years is also directed to increasing the accuracy of drug delivery and improving the biological activity of drugs. Responsive polymers to physiologically relevant signals have also been a major research hotspot. The low pH environment exhibited by human tumor sites compared to normal tissue cells is an important reference point. There is also a wealth of research into pH sensitive polymer systems.
How to design a shell cross-linked nano micelle by utilizing a pH and illumination dual stimulus responsive polymer system so as to effectively improve the stability of a nano assembly and achieve the aim of controlling the release of a medicament, which is a research subject explored by scientists on cumin.
Disclosure of Invention
The invention aims to construct a polymer nano micelle which can stably exist under the pH condition of a normal physiological environment and responds to stimulus under a weak acid environment and red light irradiation, and provides a stimulus-responsive amphiphilic block copolymer, a polymer nano shell cross-linked micelle composed of the amphiphilic block copolymer, a preparation method and application thereof.
To this end, the present invention provides the following aspects of the invention:
an amphiphilic block copolymer, comprising a hydrophilic chain segment and a hydrophobic chain segment, wherein the hydrophobic chain segment is a hydrophobic chain segment shown as the following formula A.
Formula A:
Figure BDA0002024354200000021
wherein m is 0.95-0.99, n is 0.05-0.01, and a is 52-58.
The hydrophilic chain segment is obtained by copolymerizing oligoethylene glycol methacrylate and a methacrylate compound with an aldehyde functional group for shell crosslinking, and the molecular weight of the hydrophilic chain segment is 5000-10000 Da.
<2> the amphiphilic block copolymer according to <1>, wherein the hydrophobic segment is a hydrophobic segment obtained by covalently bonding the hydrophobic segment of formula a with a photosensitizer having red light emission.
<3> the amphiphilic block copolymer according to <2>, wherein the photosensitizer having red light emission is a photosensitizer PpIX having the following formula, and the resulting hydrophobic segment represented by the following formula B,
PpIX:
Figure BDA0002024354200000022
formula B:
Figure BDA0002024354200000031
the amphiphilic block copolymer according to any one of <1> - <3>, wherein the amphiphilic block copolymer has a structure of the following formula I
Formula I:
Figure BDA0002024354200000032
wherein m is 0.95-0.99, n is 0.05-0.01, x is 0.6-0.8, y is 0.4-0.2, a is 52-58, and b is 15-20.
A method for preparing the amphiphilic block copolymer of any one of <1> to <4>, the method comprising the steps of:
a) polymerizing a micromolecular chain transfer agent with reactants shown in a formula II and a formula III to obtain a hydrophilic macromolecular chain transfer agent;
b) continuously reacting the obtained hydrophilic macromolecular chain transfer agent with reactants shown in formulas IV and V to obtain an amphiphilic block copolymer;
c) optionally, reacting the amphiphilic block copolymer obtained in b) with a photosensitizer having red light emission, preferably a photosensitizer PpIX represented by formula C below, to obtain the amphiphilic block copolymer,
formula II:
Figure BDA0002024354200000041
formula III:
Figure BDA0002024354200000042
formula IV:
Figure BDA0002024354200000043
formula V:
Figure BDA0002024354200000051
formula C:
Figure BDA0002024354200000052
[ 6 ] A polymer nanoshell crosslinked micelle obtained by shell crosslinking of the micelle using a shell crosslinking agent of formula D after assembly of the amphiphilic block copolymer of any one of <1> to <4> in an aqueous system having a pH of 7.3 to 7.4, the polymer nanoshell crosslinked micelle having a size of 50 to 80nm and having pH and red light responsivity,
formula D:
Figure BDA0002024354200000053
the amphiphilic block copolymer nanoshell crosslinked micelle of <6>, wherein the polymer nanoshell crosslinked micelle further comprises a drug to be released.
A method for controlling the dissociation of the amphiphilic block copolymer nanoshell crosslinked micelles of any one of <6> to <7>, the method comprising the steps of:
a) preparing the amphiphilic segmented copolymer nanoshell crosslinked micelle into an aqueous dispersion;
b) slowly acidifying the pH value of the obtained aqueous dispersion from the range of 7.3-7.4 to 5.0-5.5 to convert the hydrophobic chain segment in the amphiphilic block copolymer into hydrophilic;
c) irradiating with red light to dissociate the connecting part of formula D in the amphiphilic block copolymer nano-shell cross-linked micelle, and finally disintegrating the nano-micelle assembly.
The application of the amphiphilic block copolymer nanoshell crosslinked micelle as a drug carrier according to any one of <6> to <7>.
Use of the amphiphilic block copolymer nanoshell crosslinked micelle of any one of <6> to <7> for achieving controlled release of a hydrophobic drug under excitation of a weak acid microenvironment and red light irradiation.
Drawings
FIG. 1 shows NMR spectra of a hydrophilic macromolecular chain transfer agent and an amphiphilic block copolymer according to one embodiment of the present invention, used to characterize the chemical structure and chain structure of the block copolymer. Wherein, the curve a shows the nuclear magnetic resonance hydrogen spectrum of the hydrophilic macromolecular chain transfer agent, and the curve b shows the nuclear magnetic resonance hydrogen spectrum of the amphiphilic block copolymer.
Fig. 2 shows a gel permeation chromatography spectrum of a hydrophilic macromolecular chain transfer agent and an amphiphilic block copolymer according to one embodiment of the present invention, for characterization of the molecular weight and polydispersity of the block copolymer. Wherein the curve a shows the gel permeation chromatogram of the hydrophilic macromolecular chain transfer agent, and the curve b shows the gel permeation chromatogram of the amphiphilic block copolymer.
Fig. 3 shows dynamic light scattering and electron microscope photographs of an amphiphilic block copolymer nano-micelle under different pH environments and in a shell cross-linking state according to an embodiment of the present invention, where fig. a shows particle size results of a dynamic light scattering test of the amphiphilic block copolymer nano-micelle under different pH environments and in a shell cross-linking state, fig. b shows electron microscope photographs of the amphiphilic block copolymer nano-micelle under a pH of 7.3 to 7.4 and in a shell cross-linking state, and fig. c shows electron microscope photographs of the amphiphilic block copolymer nano-micelle under a pH of 5.0 to 5.5 and in a shell cross-linking state.
Fig. 4 shows the change of the photosensitizer fluorescence intensity of the amphiphilic block copolymer nanoshell crosslinked micelle in different pH environments and the corresponding fluorescence intensity normalization curve, wherein fig. a shows that the photosensitizer PpIX fluorescence emission (625nm) intensity of the nanoshell crosslinked micelle increases with the decrease of the pH value of the aqueous system, indicating the restoration of the photodynamic ability of the photosensitizer; the graph b shows the trend of the intensity of the fluorescence emission (625nm) of the photosensitizer in the shell cross-linked micelle showing corresponding changes along with the change of the pH value of the water system.
Fig. 5 shows the change of fluorescence intensity of a shell cross-linking agent of micelle particles (also called micelles) in An environment with a pH of 5 of amphiphilic block copolymer nanoshell cross-linked micelles according to An embodiment of the present invention, wherein fig. a shows the shell cross-linking agent 9, 10-aminoethoxyanthracene (An-2 NH) of the amphiphilic nanoshell cross-linked micelles under the continuous irradiation of red light (wavelength range of 570nm to 590nm) in An environment with a pH of 5.0 to 5.52) The intensity of fluorescence emission (430nm) of the micelle is continuously reduced along with the intensity of fluorescence emission, and the shell cross-linking agent is broken and dissociated from the shell layer of the micelle particle; fig. b shows the change of fluorescence emission (430nm) intensity of the shell cross-linking agent of the shell cross-linked micelle with illumination time under different pH environments, which also shows that the shell cross-linking agent can be more effectively cleaved and dissociated by continuous illumination stimulation when the shell cross-linked micelle is under the environment of pH 5.0 to 5.5.
FIG. 6 shows the pair of the change of fluorescence intensity of the cross-linking agent of the shell of the micelle particle and the change of the particle size of the micelle particle in different environments of pH 5.0-5.5 and pH 7.3-7.4 of the amphiphilic block copolymer nanoshell cross-linked micelle according to one embodiment of the present inventionThe figure shows that when the pH value is 5.0-5.5, the shell cross-linking agent is 9, 10-aminoethoxy anthracene (An-2 NH)2) The intensity of fluorescence emission (430nm) of the polymer is continuously reduced along with the increase of illumination time, the particle size of the polymer is slightly enlarged due to the initial swelling effect, then the assembly is dissociated along with the breakage of the connecting structure of the shell cross-linking agent, and finally the particle size is reduced until the state of the particle size of the single chain of the polymer is almost reached; however, when the pH value is 7.3-7.4, the fluorescence intensity of the shell cross-linking agent and the particle size of the assembly are not obviously changed, which shows good stability.
Fig. 7 shows the cumulative release curve of the hydrophobic drug Camptothecin (CPT) in the amphiphilic block copolymer nanoshell cross-linked micelles according to one embodiment of the present invention over time, which shows that at a pH of 7.3 to 7.4, the cumulative release of the drug begins to equilibrate after 17 hours in both the illuminated and non-illuminated conditions, the cumulative release of the CPT is 30% in the illuminated condition, and only 25% of the drug is released in the non-illuminated condition. And under the environment of pH 5.0-5.5, the cumulative release amount of the CPT technical can reach 80% after being irradiated by red light for 40 hours. The result shows that the shell crosslinked micelle can effectively release the loaded hydrophobic drug under the stimulation of weak acid environment and red light (the wavelength range is 570 nm-590 nm) illumination.
Detailed Description
The technical solution of the present invention is further elaborated below. It should be noted that the various embodiments of the invention may be combined in any manner as desired.
Polymeric nanomicelles are typically self-assembled from amphiphilic block copolymers, which contain an oleophilic (also called hydrophobic) core and a hydrophilic shell. Therefore, a hydrophobic substance, such as a hydrophobic drug, can be loaded into the inner core of the nanomicelle, and then the controlled release of the hydrophobic drug can be realized by designing the responsive polymer nanoparticles. However, most block copolymer nano-assemblies have stability problems, and dissociation can occur in the blood circulation process, so that the drugs are released in advance, and the circulation time of the assemblies and the drugs in vivo is shortened. Therefore, not only is a certain influence on normal cells caused, but also an ideal effect on the release of the medicine at the focus part cannot be achieved.
In the present invention, we propose a novel strategy to solve the stability problem of polymer nano-assemblies. Specifically, we have designed a block copolymer that contains a hydrophobic segment that is pH sensitive. The chain segment presents hydrophobic characteristics in neutral and alkaline environments (pH is more than 7), and the hydrophobic characteristics are changed into hydrophilic characteristics in weak acid (pH is 5-6). Photosensitizers such as protoporphyrin ix (PpIX) photosensitizers covalently bound to a hydrophobic segment aggregate together due to assembly of polymeric nanomicelles, at which time the fluorescence emission and photodynamic ability of PpIX is impaired by the photoinduced electron transfer effect (PET) of the amino groups of the micelle core layer and the self-quenching effect. When the hydrophobic chain segment of the polymer nano assembly is changed into the hydrophilic chain segment to swell, the fluorescence emission and the photodynamic capacity of PpIX are recovered, and then the external red light is used for illumination stimulation to generate singlet oxygen, so that the connection structure of the assembly shell cross-linking agent is broken, and finally the hydrophobic drug loaded in the assembly is released along with the dissociation of micelle particles.
In the present invention, a photosensitizer suitable for use is a photosensitizer having red light emission. The photosensitizer is preferably at least one selected from protoporphyrin ix (ppix) photosensitizer, eosin Y photosensitizer, porphyrin-based photosensitizer, nile blue photosensitizer, phthalocyanine photosensitizer, and the like, and most preferably protoporphyrin ix (ppix) photosensitizer.
In general, in one aspect, the invention provides an amphiphilic block copolymer derived from a hydrophilic segment and a hydrophobic segment by polymerization, such as reversible addition-fragmentation chain transfer (RAFT) polymerization. The hydrophilic chain segment of the amphiphilic block copolymer is obtained by copolymerizing oligo-polyethylene glycol methacrylate and methacrylate (such as 4-formyl phenyl oxyethyl methacrylate) with an aldehyde group functional group for shell crosslinking, and the molecular weight of the hydrophilic chain segment is 5000-10000 daltons (Da), preferably 6000-9000 Da, more preferably 6000-8000 Da, and most preferably 7000-8000 Da. The hydrophobic segment has a chemical structure represented by formula a or formula B below.
Formula A:
Figure BDA0002024354200000091
formula B:
Figure BDA0002024354200000092
wherein m is 0.95-0.99, preferably 0.96-0.98, more preferably 0.97-0.98, n is 0.05-0.01, preferably 0.04-0.02, more preferably 0.03-0.02, a is 52-58, preferably 53-57, more preferably 54-56.
The term "oligoethylene glycol methacrylate" as used herein refers to methacrylate compounds containing an oligoethylene glycol structure with a degree of polymerization in the range of 8 to 9 in the ester side group.
The term "methacrylate having an aldehyde functional group for shell crosslinking" as used herein refers to a methacrylate-based compound carrying an aldehyde functional group capable of undergoing a crosslinking reaction with the shell crosslinking agent of the present invention, and a specific example thereof is 4-formylphenoxyethyl methacrylate and the like.
In a preferred embodiment, the amphiphilic block copolymer has a chemical structure of formula I below, and a hydrophilic segment obtained by reversible addition-fragmentation chain transfer (RAFT) polymerization of oligo (ethylene glycol) methacrylate of formula II and 4-formylphenoxyethyl methacrylate of formula III, and a hydrophobic segment obtained by reversible addition-fragmentation chain transfer (RAFT) polymerization of N, N' -diisopropylaminoethyl methacrylate of formula IV and hydroxyethyl methacrylate of formula V. Finally, the amphiphilic block copolymer with the red light emitting photosensitizer (PpIX) is obtained by esterification reaction of post-modification and the formula C.
Formula I:
Figure BDA0002024354200000101
formula II:
Figure BDA0002024354200000102
formula III:
Figure BDA0002024354200000103
formula IV:
Figure BDA0002024354200000111
formula V:
Figure BDA0002024354200000112
formula C:
Figure BDA0002024354200000113
wherein m is 0.95-0.99, preferably 0.96-0.98, more preferably 0.97-0.98; n is 0.05 to 0.01, preferably 0.04 to 0.02, and more preferably 0.03 to 0.02; x is 0.6 to 0.8, preferably 0.65 to 0.8, and more preferably 0.7 to 0.8; y is 0.4 to 0.2, preferably 0.35 to 0.2, more preferably 0.3 to 0.2; a is 52-58, preferably 53-57, more preferably 54-56; b is 15 to 20, preferably 16 to 19, and more preferably 17 to 19.
In the present invention, the term "reversible addition-fragmentation chain transfer (RAFT)" has a general meaning in the field of polymer synthesis, and specifically means that a disulfide or a trithioester derivative is used as a chain transfer agent to form a dormant intermediate with radicals during polymerization, thereby limiting irreversible biradical termination side reactions between extended chain radicals and effectively controlling the polymerization reaction. Meanwhile, the dormant intermediate can be cracked by itself, new active free radicals are released from corresponding sulfur atoms, and a lengthening chain is formed by combining monomers. Since the rate of addition or cleavage is much faster than the rate of chain growth, the dithioester and trithioester derivatives rapidly migrate between the living and dormant radicals, narrowing the molecular weight distribution, and allowing the polymerization to exhibit controlled/"living" characteristics. This is a very efficient method for achieving a controlled activity of radical polymerization and has been used since 1998.
In another aspect, the invention provides a polymer nanoshell crosslinked micelle composed of the amphiphilic block copolymer, wherein the polymer nanoshell crosslinked micelle is uniformly dispersed and has a size of 50-80 nm. In a preferred embodiment, the nanomicelle size is about 50nm or so. In a further preferred embodiment, the nanomicelle has pH and red light responsiveness.
In another aspect of the present invention, there is provided a method for controlling dissociation of polymer nanoshell crosslinked micelles, the method comprising the steps of: assembling the amphiphilic segmented copolymer into an aqueous dispersion of the polymer nanoshell crosslinked micelle under the environment of pH 7.3-7.4; and then, slowly acidifying the pH value of the assembly water system from 7.3-7.4 to 5.0-5.5, stirring for a period of time, and then carrying out red light (the wavelength range is 570-590 nm) illumination stimulation from the outside, so that the cross-linked connecting part of the nano micelle shell is dissociated, and finally the nano micelle assembly is disintegrated.
In a preferred embodiment, the aqueous polymer nanomicelle dispersion is formed as follows: dissolving 5mg of the amphiphilic block copolymer in an organic solvent serving as a cosolvent, dropwise adding 9mL of deionized water with the pH value of 10-10.1 at a certain temperature under stirring, continuously stirring and volatilizing after the deionized water is dropwise added, and diluting with a phosphate buffer solution (with the pH value of 7.3-7.4) to remove the organic solvent. The shell crosslinker and sodium cyanoborohydride are then added to the micellar dispersion and after an overnight reaction, the unreacted impurities are removed by dialysis in pure water. And finally diluting the mixture to a total volume of 10mL by using a phosphate buffer solution (with the pH value of 7.3-7.4) again to obtain the 0.5mg/mL aqueous polymer nanoparticle dispersion.
In a preferred embodiment, the reaction occurs as follows: assembling, crosslinking and dispersing the amphiphilic block copolymer in an environment with the pH value of 7.3-7.4 to obtain an aqueous dispersion of the polymer nanoshell crosslinked micelle; and then, slowly acidifying the pH value of the assembly water system from the range of 7.3-7.4 to 5.0-5.5, stirring for a period of time, converting the original hydrophobic chain segment in the assembly into a hydrophilic chain segment under an acidic condition, swelling the nano-micelle, recovering the photodynamic capacity of the red light emitting photosensitizer (PpIX) covalently bonded on the hydrophobic chain segment, generating singlet oxygen under the illumination stimulation of external red light (the wavelength range is 570-590 nm), further dissociating the connecting part of the nano-micelle shell cross-linking, and finally disintegrating the nano-micelle assembly.
In another aspect, the invention provides an application of the amphiphilic block copolymer nanoshell crosslinked micelle as a drug carrier, for example, a carrier of a hydrophobic anticancer drug Camptothecin (CPT) and the like.
In another aspect, the invention provides the amphiphilic block copolymer nanoshell crosslinked micelle, which can realize the controlled release of the hydrophobic drug in a weak acid microenvironment.
In another aspect, the invention provides the use of the amphiphilic block copolymer nanoshell crosslinked micelle for achieving controlled release of a hydrophobic drug under the excitation of a weak acid microenvironment and red light irradiation.
The purpose of the invention can be realized by the following technical scheme:
first, a monomer with An aldehyde functional group for shell crosslinking is prepared by a chemical reaction in combination with organic chemistry and is named ABEMA, which is reacted with a shell crosslinking agent such as 9, 10-aminoethoxyanthracene dihydrochloride (An-2 NH)2) And carrying out chemical combination reaction to cross-link the polymer micelle particle shell. The monomer ABEMA and a shell crosslinking agent 9, 10-aminoethoxy anthracene (An-2 NH)2) Has the following structure:
Figure BDA0002024354200000131
then, oligoethylene glycol methacrylate (e.g., 475Da molecular weight) and ABEMA are polymerized, preferably by reversible addition-fragmentation chain transfer (RAFT) polymerization, followed by polymerization, preferably by reversible addition-fragmentation chain transfer (RAFT) polymerization, with N, N' -diisopropylaminoethyl methacrylate and hydroxyethyl methacrylate, using a small molecule chain transfer agent such as CEP (2-cyano-2-propyltrithiocarbonate). This gives an amphiphilic block copolymer which is finally esterified by a post-modification with a photosensitizer (e.g. PpIX) to give the final amphiphilic block copolymer with a red-emitting photosensitizer (e.g. PpIX). The micromolecule chain transfer agent CEP and the photosensitizer have the following structures:
CEP:
Figure BDA0002024354200000141
pIX:
Figure BDA0002024354200000142
eosin Y:
Figure BDA0002024354200000143
porphyrin:
Figure BDA0002024354200000144
nile blue:
Figure BDA0002024354200000151
phthalocyanine:
Figure BDA0002024354200000152
preferably, the resulting amphiphilic block copolymers of suitable hydrophilic and hydrophobic segment lengths are self-assembled using a co-solvent-water addition process. The specific process is as follows: fully dissolving a polymer in tetrahydrofuran, slowly adding deionized water with the pH value of 10-10.1 under the action of stirring at a certain temperature, continuously stirring and volatilizing after assembly to remove an organic solvent, and diluting with a phosphate buffer solution (with the pH value of 7.3-7.4). A shell crosslinking agent such as 9, 10-aminoethoxyanthracene dihydrochloride (An-2 NH) is then added to the micellar dispersion2) And sodium cyanoborohydride, and after reacting overnight, unreacted impurities were removed by dialysis in pure water. And finally diluting with phosphate buffer solution (pH 7.3-7.4) again to obtain nano particle aqueous dispersion with fifty to eighty more nano size.
By using the obtained nano-shell crosslinked micelle, the hydrophilic and hydrophobic properties of the micelle core can be changed by changing the pH value of an external water system, the nano-micelle swells after a hydrophobic chain segment is converted into a hydrophilic chain segment, then the photodynamic ability of a red light emitting photosensitizer (such as PpIX) which is covalently bonded on the hydrophobic chain segment is recovered, singlet oxygen is generated under the stimulation of external red light illumination, then the connecting structure of the nano-micelle shell crosslinking is dissociated, and finally the nano-micelle assembly is disintegrated, so that the dissociative release of the hydrophobic drug is realized.
The invention will be further illustrated by the following examples, which are intended only for the purpose of a better understanding of the invention and do not limit the scope of the invention.
Examples
Preparation example 1
Step one, preparing ABEMA containing aldehyde functional groups:
Figure BDA0002024354200000161
it is characterized in that: the monomer can be well copolymerized with hydrophilic monomer oligo-polyethylene glycol methacrylate to obtain a hydrophilic chain segment, and meanwhile, the side group of the monomer contains an aldehyde functional group, and the monomer can perform crosslinking reaction with a shell crosslinking agent 9, 10-aminoethoxy anthracene to finally obtain a shell crosslinked nano micelle assembly.
The preparation method comprises the following steps:
2.44g of 4-hydroxybenzaldehyde (guo-drug) was dissolved in 50mL of acetone, and then potassium carbonate (4.146g, 30mmol, guo-drug) and bromoethanol (3.75g, 30mmol, guo-drug) were added to the system, and refluxed overnight. The mixture was then filtered to remove inorganic salts and acetone by rotary evaporation, then extracted after dissolution in dichloromethane, the organic phase was retained, dichloromethane was removed by rotary evaporation, and finally purified by column chromatography on silica gel to give intermediate 1(1.89g, 57%). The structural formula is as follows:
Figure BDA0002024354200000162
thereafter, 1.66g of intermediate 1 was dissolved in 40mL of anhydrous dichloromethane, 2mL of triethylamine (TEA, national drug) was added in an ice bath, and 5mL of anhydrous dichloromethane in which methacryloyl chloride (1.568g, 15mmol, national drug) was dissolved was added dropwise while maintaining the ice bath. After the addition was complete, the mixture was stirred at 0 ℃ for 1h and then at room temperature for 4 h. Then washed with saturated sodium bicarbonate water, extracted three times to retain the organic phase, and dried over anhydrous sodium sulfate overnight. Finally, the monomer was isolated and purified by silica gel column chromatography to give ABEMA (1.05g, 45%).
Secondly, an amphiphilic block copolymer is further prepared by using a RAFT polymerization method, and the reaction formula of the amphiphilic block copolymer is shown as follows:
Figure BDA0002024354200000171
it is characterized in that: the copolymer chain segment of the oligo-polyethylene glycol methacrylate and the ABEMA is used as a hydrophilic chain segment, the polymerization degree of the chain segment is 15-20, wherein x is 0.6-0.8, and y is 0.4-0.2. The copolymer chain segment of the N, N' -diisopropylaminoethyl methacrylate and hydroxyethyl methacrylate is a hydrophobic chain segment, the polymerization degree of the chain segment is 52-58, wherein m is 0.95-0.99, and N is 0.05-0.01.
The preparation method comprises the following steps: to a 50mL glass sealed tube were added the chain transfer agents trithioester CEP (0.32g, 1.52mmol), oligo-ethylene glycol methacrylate OEGMA (21.66g, 45.6mmol, Aldrich's reagent), monomer ABEMA (3.56g, 15.2mmol), azobisisobutyronitrile AIBN (1.28g, 7.6mmol, national medicine) and 25mL dioxane and a stirring magneton. The whole system is degassed by three times of freezing-degassing-unfreezing circulation in a sealed tube, then the tube is sealed under the conditions of vacuum and freezing, and the polymerization reaction is carried out for 8 hours under the condition of stirring at 70 ℃. Stopping the polymerization reaction by using liquid nitrogen after the reaction is finished, opening a sealing tube to expose the system in the air, diluting the reaction mixture to room temperature, dropwise adding the diluted reaction mixture into excessive ethyl glacial ether, collecting precipitates, dissolving the precipitates by using a small amount of dichloromethane, and then precipitating in the excessive ethyl glacial ether; after this dissolution-precipitation process was repeated three times, the resulting precipitated product was dried overnight in a vacuum oven to give a hydrophilic macromolecular chain transfer agent (17.21g, 67%).
Then a 50mL glass sealed tube was charged with hydrophilic macromolecular chain transfer agent (2.28g, 0.3mmol), N, N '-diisopropylaminoethyl methacrylate (3.42g, 30mmol, Aldrich's reagent), hydroxyethyl methacrylate (1.95g, 15mmol, Shanghai SulBiotech), azobisisobutyronitrile (1.28g, 7.6mmol, Guardian) and 25mL dioxane and stirring magnetons. The whole system is degassed by three times of freezing-degassing-unfreezing circulation in a sealed tube, then the tube is sealed under the conditions of vacuum and freezing, and the polymerization reaction is carried out for 8 hours under the condition of stirring at 70 ℃. Stopping the polymerization reaction by using liquid nitrogen, opening a sealing pipe to expose the system to the air, dropwise adding the reaction mixture into excessive petroleum ether after the system is recovered to the room temperature, collecting precipitates, dissolving the precipitates by using a small amount of dichloromethane, and then precipitating in the excessive petroleum ether; after repeating the dissolution-precipitation process three times, the finally obtained precipitated product was dried overnight in a vacuum oven to obtain a yellow solid. Next, the yellow solid described above was transferred with excess azobisisobutyronitrile and DMSO solvent into a glass sealed tube and stirring magnetons were added. After the whole system is degassed by three times of freezing-degassing-unfreezing cycles in a sealed tube, the tube is sealed under the conditions of vacuum and freezing, and the polymerization reaction is carried out for 2 hours under the stirring condition at 70 ℃. Stopping the polymerization reaction by using liquid nitrogen after the reaction is finished, opening a sealing pipe to expose the system in the air, diluting the reaction mixture to room temperature, dripping the diluted reaction mixture into excessive petroleum ether, collecting precipitates, dissolving the precipitates by using a small amount of dichloromethane, and then precipitating in the excessive petroleum ether; after repeating the dissolution-precipitation process three times, the finally obtained precipitated product was dried overnight in a vacuum oven to finally obtain 4.32g (56%) of a white solid polymer.
The chemical structures and chain structures of the hydrophilic macromolecular chain transfer agent and the amphiphilic block copolymer, and the molecular weight and molecular weight distribution thereof are respectively obtained by nuclear magnetic resonance hydrogen spectrum and gel permeation chromatography tests, and the results are respectively shown in fig. 1 and fig. 2.
Thirdly, the final amphiphilic block copolymer is subjected to esterification reaction with a photosensitizer with carboxylic acid groups through post-modification to obtain the final amphiphilic block copolymer with the red light emitting photosensitizer (PpIX), and the esterification reaction and the structural formula of the photosensitizer are shown as follows:
Figure BDA0002024354200000181
the preparation method comprises the following steps: 4.3g of the polymer obtained in the second step, 4-dimethylaminopyridine (DMAP, 0.03g, Chinese medicine), dicyclohexylcarbodiimide (DCC, 0.1g, Chinese medicine), and a photosensitizer protoporphyrin IX (PpIX, 0.15g, Aldrich reagent) were dissolved in anhydrous dichloromethane. And stirred at room temperature overnight. The unmodified photosensitizer protoporphyrin IX was then removed by basic alumina column chromatography. The product was finally spin dried to give 3.92g (88%) of a polymer as a dark red solid powder.
The fourth step: self-assembly of an amphiphilic block copolymer loaded with hydrophobic drug Camptothecin (CPT) is carried out to prepare the nano-shell cross-linked micelle particle. The method comprises the following specific steps:
first 5mg of polymer and 1mg of camptothecin were weighed out and dissolved in THF (1 mL). Then, 9mL of deionized water (pH 10-10.1) was added at a rate of 9mL/h at room temperature. The organic solvent is then evaporated under agitation and the undissolved hydrophobic anticancer drug is removed by filtration through a water filtration membrane. Finally, the assembly is dissolved by deionized waterAfter diluting to 9mL, the solution was diluted with phosphate buffer (PBS, 0.2mol/L, pH 7.3-7.4, Chinese medicine) to a total volume of 10 mL. Then, 2mL of the micelle dispersion (0.5g/L, PBS, 0.02mol/L, pH 7.3-7.4) was added with 9, 10-aminoethoxyanthracene dihydrochloride (An-2 NH)2) And stirred at room temperature for 4 h. Then NaBH is added3CN (0.1mg, Chinese medicine) is used for reducing imine bonds to obtain the final shell crosslinked nano micelle particles. After the reaction overnight, unreacted impurities were removed by dialysis against pure water. And finally, diluting the mixture by using phosphate buffer solution (PBS, 0.2mol/L, pH 7.3-7.4, Chinese medicine) to the total volume of 2mL to obtain the polymer nanoshell crosslinked micelle particle loaded with the hydrophobic medicine camptothecin.
The nanoparticles obtained as described above are characterized as follows:
1) the nano micelle particle is characterized in that a hydrophilic shell layer is formed by a copolymerization chain segment of oligo-polyethylene glycol methacrylate and ABEMA, and a hydrophobic core is formed by a copolymerization chain segment of N, N' -diisopropylaminoethyl methacrylate and a methacrylate monomer connected with a photosensitizer. The particle size is about 50nm, and the size distribution is uniform. Figure 3 shows dynamic light scattering data and a TEM photograph.
2) The polymer nanoshell crosslinked micelle particles can stably exist in neutral and alkaline environments, and can effectively dissociate and release the internally coated hydrophobic drug in a weakly acidic environment and under red light illumination. Fig. 4 shows that the shell-crosslinked micelle particles effectively respond to a weak acid environment. FIG. 5 shows that the shell-crosslinked micelle particle assembly dissociates to release the hydrophobic drug only after illumination with red light in a weak acid environment.
The fifth step: a method for controlling the dissociation of amphiphilic block copolymer nanoshell crosslinked micelle particles. The method comprises the following specific steps:
and (2) under the conditions that the pH value of the aqueous dispersion of the polymer nanoshell crosslinked micelle particles is 7.3-7.4 and the temperature is 37 ℃, the pH value of the obtained aqueous dispersion of the polymer nanoshell crosslinked micelle particles is slowly adjusted from 7.3-7.4 to 5.0-5.5. The original hydrophobic chain segment is changed into hydrophilicity, and the shell crosslinked micelle particle assembly swells. The system is then illuminated with a red light source. At this time, the photosensitizer located in the micelle core layer recovers its photodynamic ability due to the swelling of the assembly, and it can efficiently generate singlet oxygen under illumination of red light wavelength. Then the shell layer cross-linked structure is broken under the action of singlet oxygen. Finally, the assembly is dissociated to release the hydrophobic drug. FIG. 6 shows that the assembly is relatively stable at pH 7.3-7.4, and the assembly can be effectively dissociated at pH 5.0-5.5 under red (580nm) light.
Application example 1: loading and controllable release of amphiphilic block copolymer nanoshell crosslinked micelle particle on hydrophobic drug
In the prepared polymer nanoshell crosslinked micelle particle loaded with the hydrophobic drug camptothecin, a fluorescence spectrum is utilized to track the release process of Camptothecin (CPT) technical from a hydrophobic region of the micelle nanoparticle under the condition of weakly acidic pH value and under the condition of red light irradiation. First, 0.3mL of drug-loaded shell cross-linked micelle with a mass concentration of 0.5mg/mL was added to each of the four dialysis dishes. The pH value of two systems is 5.0-5.5, and the pH value of the other two systems is 7.3-7.4. One set of the systems with different pH values was illuminated with red light (580nm) at room temperature, and the other two sets were placed in a dark room. Measuring ultraviolet absorption of camptothecin in the dialysate at 228nm at intervals, and periodically updating the dialysate to replace the dialysate with phosphate buffer solution with corresponding volume and pH value. The cumulative release of CPT was calculated from the previously measured standard UV absorption curve of CPT at 228 nm. The results show that the hydrophobic drug can exist in the assembly stably in relative terms under the environment with the pH value of 7.3-7.4. And when the pH value is 5.0-5.5, the hydrophobic drug can be effectively released, and especially under the condition of combining with red light (580nm), the cumulative release amount can reach as much as 80%. Figure 7 shows the cumulative release profile of camptothecin encapsulated in a hydrophobic core in various pH environments and in the absence of light.
Industrial applicability
The invention realizes the controllable release of the hydrophobic drug loaded by the polymer nano-shell cross-linked micelle carrier, simultaneously, the photosensitizer with red light emission combined by covalent bonds in the amphiphilic segmented copolymer and the hydrophobic chain segment with hydrophobic property in neutral and alkaline environments are matched by the aldehyde functional group for shell cross-linking, and the controllable release of the drug can be accurately realized in the microenvironment of weak acid and under the excitation of red light irradiation, so the invention has great potential industrial application in the aspect of being used as a drug carrier or the controllable release of the drug.

Claims (10)

1.一种两亲性嵌段共聚物,所述两亲性嵌段共聚物包括亲水链段和疏水链段,所述疏水链段为下式A的疏水链段与具有红光发射的光敏剂共价键结合而得到的疏水链段,1. An amphiphilic block copolymer comprising a hydrophilic segment and a hydrophobic segment, wherein the hydrophobic segment is a hydrophobic segment of the following formula A and a The hydrophobic segment obtained by covalent bonding of photosensitizers, 式A:Formula A:
Figure FDA0002746682790000011
Figure FDA0002746682790000011
其中m=0.95~0.99,n=0.05~0.01,a=52~58,其中所述亲水链段是由寡聚乙二醇甲基丙烯酸酯与带有用于壳交联的醛基功能团的甲基丙烯酸酯类化合物共聚得到,并且所述亲水链段分子量为5000~10000道尔顿(Da)。wherein m=0.95~0.99, n=0.05~0.01, a=52~58, wherein the hydrophilic segment is composed of oligoethylene glycol methacrylate and an aldehyde functional group for shell crosslinking The methacrylate compound is obtained by copolymerization, and the molecular weight of the hydrophilic segment is 5000-10000 Daltons (Da).
2.根据权利要求1所述两亲性嵌段共聚物,其中所述具有红光发射的光敏剂为具有下式结构的光敏剂PpIX,并且得到下式B所示的疏水链段,2. The amphiphilic block copolymer according to claim 1, wherein the photosensitizer with red light emission is a photosensitizer PpIX having the following formula, and a hydrophobic segment shown in the following formula B is obtained, PpIX:PpIX:
Figure FDA0002746682790000012
Figure FDA0002746682790000012
式B:Formula B:
Figure FDA0002746682790000021
Figure FDA0002746682790000021
3.根据权利要求1-2中任一项所述的两亲性嵌段共聚物,其中所述两亲性嵌段共聚物具有下式I结构,3. The amphiphilic block copolymer of any one of claims 1-2, wherein the amphiphilic block copolymer has the following formula I structure, 式I:Formula I:
Figure FDA0002746682790000022
Figure FDA0002746682790000022
其中m=0.95~0.99,n=0.05~0.01,x=0.6~0.8,y=0.4~0.2,a=52~58,b=15~20。Wherein m=0.95~0.99, n=0.05~0.01, x=0.6~0.8, y=0.4~0.2, a=52~58, b=15~20.
4.一种制备权利要求1-3中任一项所述的两亲性嵌段共聚物的方法,所述方法包括以下步骤:4. A method of preparing the amphiphilic block copolymer of any one of claims 1-3, the method comprising the steps of: a)用小分子链转移剂与式II和式III所示的反应物聚合而获得亲水性大分子链转移剂;a) polymerizing with a small molecular chain transfer agent and the reactants shown in formula II and formula III to obtain a hydrophilic macromolecular chain transfer agent; b)由上述得到的亲水性大分子链转移剂再继续与式IV和式V所示的反应物反应而获得两亲性嵌段共聚物;b) the above-obtained hydrophilic macromolecular chain transfer agent continues to react with the reactants shown in formula IV and formula V to obtain an amphiphilic block copolymer; c)将b)所获得的两亲性嵌段共聚物与具有红光发射的光敏剂反应,得到所述两亲性嵌段共聚物,c) reacting the amphiphilic block copolymer obtained in b) with a photosensitizer having red light emission to obtain the amphiphilic block copolymer, 式II:Formula II:
Figure FDA0002746682790000031
Figure FDA0002746682790000031
式III:Formula III:
Figure FDA0002746682790000032
Figure FDA0002746682790000032
式IV:Formula IV:
Figure FDA0002746682790000033
Figure FDA0002746682790000033
式V:Formula V:
Figure FDA0002746682790000034
Figure FDA0002746682790000034
5.根据权利要求4所述的方法,其中所述具有红光发射的光敏剂为下面式C所示的光敏剂PpIX,5. The method according to claim 4, wherein the photosensitizer with red light emission is the photosensitizer PpIX shown in the following formula C, 式C:Formula C:
Figure FDA0002746682790000041
Figure FDA0002746682790000041
6.一种聚合物纳米壳交联胶束,其中,在pH=7.3-7.4的水体系中由权利要求1-3任一项所述的两亲性嵌段共聚物组装成胶束后,使用式D的壳交联剂将所述胶束壳交联而获得,所述聚合物纳米壳交联胶束的尺寸为50~80nm,并且具有pH以及红光光响应性,6. A polymer nanoshell cross-linked micelle, wherein, after the amphiphilic block copolymer according to any one of claims 1-3 is assembled into micelles in an aqueous system of pH=7.3-7.4, The micelle shell is obtained by cross-linking the shell cross-linking agent of formula D, the size of the polymer nano-shell cross-linked micelle is 50-80 nm, and has pH and red light responsiveness, 式D:Formula D:
Figure FDA0002746682790000042
Figure FDA0002746682790000042
7.根据权利要求6所述的两亲性嵌段共聚物纳米壳交联胶束,其中所述聚合物纳米壳交联胶束还包含有待释放的药物。7. The amphiphilic block copolymer nanoshell crosslinked micelle of claim 6, wherein the polymer nanoshell crosslinked micelle further comprises a drug to be released. 8.一种控制权利要求6-7中任一项所述的两亲性嵌段共聚物纳米壳交联胶束解离的方法,所述方法包括以下步骤:8. A method for controlling the dissociation of the amphiphilic block copolymer nanoshell cross-linked micelles described in any one of claims 6-7, the method comprising the steps of: a)将所述两亲性嵌段共聚物纳米壳交联胶束制备成水分散液;a) preparing the amphiphilic block copolymer nanoshell cross-linked micelle into an aqueous dispersion; b)将所得水分散液的pH值由7.3-7.4的范围慢慢酸化至5.0-5.5,以使得所述两亲性嵌段共聚物中的疏水链段转变成亲水性;b) slowly acidifying the pH value of the obtained aqueous dispersion from the range of 7.3-7.4 to 5.0-5.5, so that the hydrophobic segment in the amphiphilic block copolymer is converted into hydrophilic; c)用红光光照,以将所述的两亲性嵌段共聚物纳米壳交联胶束中的式D的连接部分解离,最后瓦解纳米胶束组装体。c) irradiating with red light to dissociate the connecting part of formula D in the amphiphilic block copolymer nanoshell cross-linked micelle, and finally disintegrate the nanomicelle assembly. 9.根据权利要求6-7中任一项所述的两亲性嵌段共聚物纳米壳交联胶束作为药物载体的应用。9. The application of the amphiphilic block copolymer nanoshell cross-linked micelle according to any one of claims 6-7 as a drug carrier. 10.根据权利要求6-7中任一项所述的两亲性嵌段共聚物纳米壳交联胶束用于在弱酸的微环境和红光照射的激发下实现疏水药物的可控释放的用途。10. The amphiphilic block copolymer nanoshell cross-linked micelle according to any one of claims 6-7 is used to realize the controlled release of hydrophobic drugs under the excitation of weak acid microenvironment and red light irradiation. use.
CN201910291982.7A 2019-04-11 2019-04-11 Amphiphilic block copolymer, shell-crosslinked micelle thereof, preparation method and application Active CN110041475B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910291982.7A CN110041475B (en) 2019-04-11 2019-04-11 Amphiphilic block copolymer, shell-crosslinked micelle thereof, preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910291982.7A CN110041475B (en) 2019-04-11 2019-04-11 Amphiphilic block copolymer, shell-crosslinked micelle thereof, preparation method and application

Publications (2)

Publication Number Publication Date
CN110041475A CN110041475A (en) 2019-07-23
CN110041475B true CN110041475B (en) 2021-02-12

Family

ID=67276869

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910291982.7A Active CN110041475B (en) 2019-04-11 2019-04-11 Amphiphilic block copolymer, shell-crosslinked micelle thereof, preparation method and application

Country Status (1)

Country Link
CN (1) CN110041475B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110859965B (en) * 2019-12-17 2023-07-07 深圳大学 Multifunctional nanoparticle with AIE characteristics and preparation method and application thereof
CN113087929B (en) * 2021-03-08 2021-12-03 华中科技大学 Hydrogen bond supermolecule polymer nano-particle and preparation method thereof
CN113087770B (en) * 2021-04-22 2023-06-16 中国科学技术大学 Light-responsive polypeptide derivative, polypeptide nanomaterial, preparation method and application of polypeptide nanomaterial
CN113384709B (en) * 2021-06-28 2022-03-11 西南大学 Preparation and application of a dextran-protoporphyrin prodrug nanomicelle
CN114158551B (en) * 2021-11-22 2022-09-30 定远众邦生物工程有限公司 Nano pesticide preparation capable of rapidly responding to weak alkaline environment, preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452925A (en) * 1981-02-09 1984-06-05 National Patent Development Corporation Biologically stabilized compositions comprising collagen as the minor component with ethylenically unsaturated compounds used as contact lenses
CN101935373B (en) * 2010-08-05 2011-12-07 江南大学 Preparation method of multi-sensitivity photosensitive polyamphoteric electrolyte micelle
US20130177976A1 (en) * 2011-07-25 2013-07-11 Kaohsiung Medical University Combination of cationic polymers and polysaccharides nanoparticles as a gene carrier
CN102633960A (en) * 2012-04-01 2012-08-15 华东理工大学 Multi-environmentally responsive tri-block copolymer and its preparation method and application
CN103923277B (en) * 2014-04-28 2016-06-29 苏州大学 A kind of amphipathic nature polyalcohol, its preparation method, composite Nano pharmaceutical carrier and preparation method thereof
CN104231155B (en) * 2014-08-19 2016-08-17 华南理工大学 Cholesterol modifies amphipathic pH response brush copolymer and preparation and micella thereof

Also Published As

Publication number Publication date
CN110041475A (en) 2019-07-23

Similar Documents

Publication Publication Date Title
CN110041475B (en) Amphiphilic block copolymer, shell-crosslinked micelle thereof, preparation method and application
Duan et al. Light-triggered nitric oxide (NO) release from photoresponsive polymersomes for corneal wound healing
CN106265509B (en) A kind of pH and Redox dual-responsive amphiphilic block copolymer and its preparation method and use
CN107641181B (en) Diblock copolymer with light and pH dual responsiveness and preparation method thereof
CN108752594B (en) Amphipathic block polymer based on azo reductase response and preparation method and application thereof
CN102702454A (en) PH response four-arm star block copolymer and preparation method and application thereof
CN113105614A (en) Easily degradable responsive core-crosslinkable amphiphilic block polymer, preparation method thereof and application of polymer as drug carrier
CN106279581B (en) A pH-responsive/membrane-adhesive amphiphilic block copolymer and preparation method thereof
CN102093555A (en) Polymer nano hydrogel and preparation method thereof
CN107722200B (en) Multiple stimuli-responsive Fe3O4 graft copolymer hybrid and its preparation method and application
CN108524529A (en) Sensitivity to acid adriamycin prodrug and the preparation method and application thereof based on amphoteric ion and folate-targeted
CN108948265B (en) Nano-carrier with photoresponse and preparation method thereof
CN109796374B (en) Light-responsive nitric oxide donor molecule and its derivatives and preparation methods
CN111320732A (en) Amphiphilic block copolymer with near-infrared thermal responsiveness and preparation and application thereof
CN109320636B (en) Triple stimulus-responsive core-crosslinked polymer micelle and preparation method and application thereof
CN113082206B (en) Macromolecule nitric oxide donor modified up-conversion nanoparticle, preparation method and application
CN111592634B (en) Photoreduction self-degradation polymer and preparation method and application thereof
Feng et al. Poly (amino acid) s-based star AIEgens for cell uptake with pH-response and chiral difference
CN104311889A (en) Preparation method of polycaprolactone/polyethylene glycol hydrogel used for photodynamic therapy
CN104173282B (en) Folate-targeted acid-sensitive core crosslinking carrier micelle based on poly phosphate and preparation method thereof
CN107011515B (en) A kind of triblock polymer and preparation method thereof
He et al. Visible light-responsive micelles enable co-delivery of nitric oxide and antibiotics for synergistic antibiofilm applications
CN110642968B (en) Dual-enzyme-responsive dumbbell-shaped super-amphiphilic molecule and preparation method and use thereof
CN113440612B (en) Photodynamic enhanced polymer nanogel, preparation method and application thereof
CN107118295A (en) A kind of polymer nanocomposite gel, preparation method and applications

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant